Options
Fusobacterium nucleatum is associated with inflammation and poor survival in early-stage HPV-negative tongue cancer
Journal
NAR Cancer
Date Issued
2022-03-01
Author(s)
Desai, Sanket
Dharavath, Bhasker
Manavalan, Sujith
Rane, Aishwarya
Redhu, Archana Kumari
Sunder, Roma
Butle, Ashwin
Mishra, Rohit
Joshi, Asim
Togar, Trupti
Apte, Shruti
Bala, Pratyusha
Chandrani, Pratik
Chopra, Supriya
Bashyam, Murali Dharan
Banerjee, Anirban
Prabhash, Kumar
Nair, Sudhir
Dutt, Amit
Abstract
Persistent pathogen infection is a known cause of malignancy, although with sparse systematic evaluation across tumor types. We present a comprehensive landscape of 1060 infectious pathogens across 239 whole exomes and 1168 transcriptomes of breast, lung, gallbladder, cervical, colorectal, and head and neck tumors. We identify known cancer-associated pathogens consistent with the literature. In addition, we identify a significant prevalence of Fusobacterium in head and neck tumors, comparable to colorectal tumors. The Fusobacterium-high subgroup of head and neck tumors occurs mutually exclusive to human papillomavirus, and is characterized by overexpression of miRNAs associated with inflammation, elevated innate immune cell fraction and nodal metastases. We validate the association of Fusobacterium with the inflammatory markers IL1B, IL6 and IL8, miRNAs hsa-mir-451a, hsa-mir-675 and hsa-mir-486-1, and MMP10 in the tongue tumor samples. A higher burden of Fusobacterium is also associated with poor survival, nodal metastases and extracapsular spread in tongue tumors defining a distinct subgroup of head and neck cancer.
Volume
4